HighVista Strategies’s Chemed CHE Stock Holding History

HighVista Strategies’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-900	Closed	-$255K	–	120
2018 Q4	$255K	Buy	+900	New	+$272K	0.22%	83

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighVista Strategies's CHE Position: Q1 2019 in Review

HighVista Strategies sold out of Chemed (CHE) in Q1 2019, closing a stake of 900 shares — an estimated $255K sold.

HighVista Strategies first reported a position in CHE in Q4 2018 and held it in 1 quarter. The position peaked at $255K in Q4 2018. 382 funds tracked by Wall St. Rank hold CHE as of Q1 2019.

HighVista Strategies reported no remaining Chemed position as of Q1 2019 after selling out during the quarter.
HighVista Strategies sold 900 Chemed shares in Q1 2019, an estimated $255K.
HighVista Strategies first reported a position in Chemed in Q4 2018 and held it in 1 quarter.
HighVista Strategies's Chemed position peaked at $255K in Q4 2018.
382 funds tracked by Wall St. Rank held Chemed as of Q1 2019.

Based on HighVista Strategies's 13F filing for Q1 2019, filed 15 May 2019.